Research programme: YSAVA monoclonal antibody - Y's Therapeutics
Alternative Names: AntVec monoclonal antibody series; YSAVA monoclonal antibody research programme - Y's Therapeutics; YSAVA-1L; YSAVA-3LLatest Information Update: 23 Sep 2009
Price :
$50 *
At a glance
- Originator Ys Therapeutics
- Class Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 19 Jul 2005 This programme is still in active development
- 12 Mar 2004 Preclinical trials in Solid tumours in Japan (unspecified route)